Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting
April 26, 2024 06:30 ET
|
Ocugen
MALVERN, Pa., April 26, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
Fluxys hydrogen désigné comme "gestionnaire du réseau de transport d'hydrogène" en Belgique
April 26, 2024 02:30 ET
|
Fluxys
Bruxelles - 26 avril 2024 - En exécution de la loi fédérale sur l'hydrogène du 11 juillet 2023, la ministre fédérale de l'Energie, Tinne Van der Straeten, a désigné Fluxys hydrogen, une filiale de...
Fluxys hydrogen benoemd als “waterstof vervoersnetbeheerder” in België
April 26, 2024 02:30 ET
|
Fluxys
Brussel – 26 april 2024 – In uitvoering van de federale waterstofwet van 11 juli 2023, heeft de federale Minister van Energie Tinne Van der Straeten, Fluxys hydrogen, een dochteronderneming van...
Fluxys hydrogen appointed as “Hydrogen Network Operator” in Belgium
April 26, 2024 02:30 ET
|
Fluxys
Brussels - 26 April 2024 - Implementing the Federal Hydrogen Act of 11 July 2023, Federal Energy Minister Tinne Van der Straeten has appointed Fluxys hydrogen, a subsidiary of Fluxys Belgium, as...
Falcon Oil & Gas Ltd - Full Year Results
April 26, 2024 02:00 ET
|
Falcon Oil & Gas Ltd.
FALCON OIL & GAS LTD. (“Falcon”) Full Year Results 26 April 2024 - Falcon Oil & Gas Ltd. (TSXV: FO, AIM: FOG) is pleased to announce its financial results for the year ended 31...
JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension
April 26, 2024 01:00 ET
|
Idorsia Pharmaceuticals Ltd
Ad hoc announcement pursuant to Art. 53 LR Idorsia receives a positive opinion from the Committee for Medicinal Products for Human Use for JERAYGO™ (aprocitentan) as the first and only endothelin...
JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension
April 26, 2024 01:00 ET
|
Idorsia Pharmaceuticals Ltd
Ad hoc announcement pursuant to Art. 53 LR Idorsia receives a positive opinion from the Committee for Medicinal Products for Human Use for JERAYGO™ (aprocitentan) as the first and only endothelin...
Amundi: Résultats du premier trimestre 2024
April 26, 2024 00:59 ET
|
Amundi
Amundi: Résultats du premier trimestre 2024 Encours gérés au plus haut historiqueCollecte dynamique de +17 Md€, résultat net1,2 en hausse de +6% T1/T1 Un résultat net en hausse Haut niveau de...
NFM Lending Wins 2024 Culture Excellence Awards from Top Workplaces
April 25, 2024 22:51 ET
|
NFM Lending
Linthicum, MD, April 25, 2024 (GLOBE NEWSWIRE) -- NFM Lending and its family of lenders have announced today that it is a 2024 Top Workplaces Culture Excellence honoree. Top Workplaces Culture...
GLOBAL CORD ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Global Cord Blood Corporation and Encourages Investors to Contact the Firm
April 25, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Global...